Literature DB >> 26406097

New designed nerve conduits with a porous ionic cross-linked alginate/chitisan structure for nerve regeneration.

Jen-Ray Chaw1, Hsia-Wei Liu2, Yu-Chao Shih3,4, Ching-Cheng Huang4,5.   

Abstract

A new fabrication process for designing nerve conduits with a porous ionic cross-linked alginate/chitosan composite for nervous regeneration could be prepared. New designed nerve conduits with a porous ionic cross-linked alginate/chitosan composite were developed for nervous regeneration. Nerve conduits (NCs) represent a promising alternative to conventional treatments for peripheral nerve repair. NCs composed of various polysaccharides such as sodium alginate were designed and prepared by lyophilization as potential matrices for tissue engineering. The use of a porous ionic cross-linked alginate/chitosan composite could provide penetration channels that would lead to the products' increasing penetration rate properties. Furthermore, the use of a porous ionic cross-linked alginate/chitosan composite also has a highly cross-linked structure, which would give the products relatively good mechanical properties. Furthermore, the drug could be incorporated into nerve conduits as a new drug-carrying system for nerve regeneration because of its porous and cross-linked structures.

Entities:  

Keywords:  Cross-linking reaction; composite; drug-release systems

Mesh:

Substances:

Year:  2015        PMID: 26406097     DOI: 10.3233/BME-151294

Source DB:  PubMed          Journal:  Biomed Mater Eng        ISSN: 0959-2989            Impact factor:   1.300


  2 in total

Review 1.  Polymer Scaffolds for Biomedical Applications in Peripheral Nerve Reconstruction.

Authors:  Meng Zhang; Ci Li; Li-Ping Zhou; Wei Pi; Pei-Xun Zhang
Journal:  Molecules       Date:  2021-05-05       Impact factor: 4.411

2.  ALG-bFGF Hydrogel Inhibiting Autophagy Contributes to Protection of Blood-Spinal Cord Barrier Integrity via PI3K/Akt/FOXO1/KLF4 Pathway After SCI.

Authors:  Renkan Zhang; Ling Xie; Fangfang Wu; Ji Xu; Leilei Lu; Lin Cao; Lei Li; Weiyang Meng; Hongyu Zhang; Chuxiao Shao; Xiaokun Li; Daqing Chen
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.